| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |